Nicotinic Receptors and Schizophrenia.

Trial Profile

Nicotinic Receptors and Schizophrenia.

Phase of Trial: Phase I

Latest Information Update: 15 Feb 2016

At a glance

  • Drugs GTS 21 (Primary)
  • Indications Schizophrenia
  • Focus Pharmacokinetics
  • Most Recent Events

    • 01 Jan 2013 Status changed from recruiting to completed as reported by
    • 17 Nov 2011 Planned End Date changed from 1 Jan 2014 to 1 Jan 2015 as reported by
    • 19 May 2010 Planned end date changed from 1 Sep 2011 to 1 Jan 2014 as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top